Pure Global

“Meril” Biomime Morph Sirolimus Eluting Coronary Stent System - Taiwan Registration a574bd92571df595ab98b7aed05b3e6e

Access comprehensive regulatory information for “Meril” Biomime Morph Sirolimus Eluting Coronary Stent System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number a574bd92571df595ab98b7aed05b3e6e and manufactured by Meril Life Sciences Pvt. Ltd.. The authorized representative in Taiwan is K&C MEDICAL CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
a574bd92571df595ab98b7aed05b3e6e
Registration Details
Taiwan FDA Registration: a574bd92571df595ab98b7aed05b3e6e
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“Meril” Biomime Morph Sirolimus Eluting Coronary Stent System
TW: “渼瑞爾”拜歐邁茉福冠狀動脈塗藥支架系統
Risk Class 3
MD

Registration Details

a574bd92571df595ab98b7aed05b3e6e

Ministry of Health Medical Device Import No. 031612

DHA05603161207

Company Information

Product Details

For details, it is Chinese approved copy of the imitation order

E Cardiovascular devices

E0001 Cardiovascular stents

Imported from abroad

Dates and Status

Jun 10, 2019

Jun 10, 2024